-
Cut off from the West, Muscovites rediscover Russian 'roots'
-
'Joint venture in reverse': foreign carmakers seek edge with China partners
-
Nations backing fossil fuel exit 'a new power': conference host Colombia
-
Rockets thrash Lakers, Wembanyama triumphant on Spurs return
-
ECB set to hold rates steady with eye on Iran crisis
-
Team-first Kane propelling Bayern to glory as PSG showdown looms
-
Pogacar vows to keep going until Seixas 'destroys' him
-
From Adele to Raye, the UK school nurturing future stars
-
Final talks begin on missing piece for pandemic treaty
-
Oil rises, stocks swing as peace talk hopes wobble
-
'Heartbroken' Xavi Simons out of World Cup and Spurs relegation fight
-
North Korea's Kim reaffirms support for Russia's 'sacred' Ukraine war
-
Spurs win in Wembanyama return to take 3-1 lead over Trail Blazers
-
As some hijabs come off in Iran, restrictions still in place
-
Orangutan uses Indonesia canopy bridge in 'world first': NGO
-
Dealing with the dead in the ruins of Sudan's war
-
North Korea strengthens nuclear push as US flails in Middle East
-
Stage set for Elon Musk's court battle with OpenAI
-
Caught between wars, US Afghan allies trapped in Qatar without safe exit
-
British royals begin four-day US visit despite shooting
-
Suspect in shooting at Trump press dinner to appear in court
-
Fitzpatrick brothers capture PGA Tour's Zurich Classic pairs crown
-
Spurs win in Wembanyama return to take 3-1 lead on Trail Blazers
-
Toulouse fall to first home defeat for a year
-
Global military spending surges on insecurity: report
-
Marseille see Champions League chance slip further away
-
Nelly Korda wins LPGA Chevron Championship
-
Syrian court begins proceedings against Assad and allies
-
Colombia road bombing death toll rises to 20
-
Raptors top Cavs to pull level in NBA playoff series
-
Iran minister heads to Russia as talks remain stalled
-
Rinku stars as Kolkata edge Lucknow in Super Over
-
T'Wolves Edwards to miss several weeks - report
-
Michael Jackson biopic debuts atop N. America box office
-
King Charles state visit to US to go on as planned after shooting
-
Inter pegged back by Torino as Serie A title charge hits bump in road
-
Mali junta in crisis after minister killed, key city 'captured'
-
Dortmund down Freiburg to seal Champions League spot
-
McFarlane hails Chelsea 'character' after FA Cup semi-final win
-
Gunman sought to kill Trump, cabinet at gala dinner
-
Arsenal punish Lyon errors in Champions League semi
-
Suspect in US press gala shooting - what we know
-
Key US senator lifts block on Fed chair nominee
-
Attacks in Mali: What we know
-
Vollering wins women's Lige-Bastogne-Liege for 3rd time
-
Sinner motors on in Madrid as Gauff overcomes stomach bug
-
Fernandez sends Chelsea into FA Cup final to lift gloom after Rosenior sacking
-
Colombia road bombing death toll rises to 19
-
Stuttgart stumble against Bremen in top-four race
-
Two former Israel PMs unite to challenge Netanyahu in elections
Big Bold Health(R) Launches Large-Scale Randomized Clinical Trial Evaluating Himalayan Tartary Buckwheat Sprout Powder
Study of 850 participants believed to be the largest randomized, placebo-controlled trial ever conducted on a single food ingredient, brain health, and immunity.
BAINBRIDGE ISLAND, WA / ACCESS Newswire / February 17, 2026 / Big Bold Health® today announced the launch of an ongoing randomized, placebo-controlled clinical trial evaluating Himalayan Tartary Buckwheat (HTB) Sprout Powder, a whole-food ingredient rich in naturally occurring plant polyphenols. The study, which has now completed enrollment of 850 participants, is believed to be the largest randomized placebo-controlled trial ever conducted on a single food ingredient focused on brain health and immune function.
This IRB-approved study is designed to evaluate the effects of HTB Sprout Powder using objective clinical measurements under controlled conditions. While outcomes are not yet known, the scale and rigor of the trial reflect growing scientific interest in applying modern clinical research methods to whole foods and dietary interventions.
"This study represents an important evolution in how we evaluate nutrition," said Jeffrey Bland, PhD, Founder and President of Big Bold Health®. "For many years, nutrition science has focused on isolated nutrients rather than whole foods. By conducting a large randomized clinical trial on a single food, we hope to contribute to a deeper understanding of how complex plant systems interact with human biology. The goal is to advance the science itself, independent of any predetermined outcome."
Lead on the trial from Big Bold Health® is Austin Perlmutter, MD, Chief Science Officer. According to Dr. Perlmutter, the study reflects a broader effort to bring greater scientific clarity to food-based interventions. "Eating certain foods has been convincingly linked to better health, including improved brain function, immune function, and metabolic function," said Dr. Perlmutter. "Our aim is to explore the 'how' with the largest study ever done of its kind. We're studying a uniquely nutrient rich food-sprouted Himalayan Tartary Buckwheat-with a rigorous and transparent process, allowing the data to guide future understanding of how food can promote health. Completing enrollment is an important milestone, and we look forward to sharing results once the study is complete."
Himalayan Tartary Buckwheat is an ancient crop traditionally consumed in parts of Asia and more recently reintroduced to U.S. agriculture through regenerative farming initiatives. Big Bold Health has supported research efforts around the crop as part of its broader mission to explore the intersection of nutrition, immunity, human longevity, and ecological health.
Results from the study will be analyzed following completion of the intervention period and are expected to contribute to the growing body of research examining the role of whole foods in human health.
About Big Bold Health®
Big Bold Health® is on a mission to establish global awareness of longevity through immune health. From revitalizing lost superfoods to crafting high-quality omega-3 products, Big Bold Health® draws from the best immunity interventions nature can offer. With an unparalleled dedication to science, sustainability, and quality, Big Bold Health® supports enduring wellness for people, plants, and planet. For more information, visit https://bigboldhealth.com.
Media Contact
Trish Eury
Senior Director of Communications
[email protected]
SOURCE: Big Bold Health
View the original press release on ACCESS Newswire
O.M.Souza--AMWN